Cogstate jumps 51pc on Alzheimer’s drug news
MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, rocketed 60… read more
New Alzheimer’s drug unlikely to be approved in Australia
CANBERRA: A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive… read more
End ‘vaccine frustration’ and let pharmacies join rollout
MELBOURNE: New South Wales, Victoria and Western Australia could all soon join Queensland in allowing… read more
